NCT03016494View on ClinicalTrials.gov

Safety and Pharmacokinetics Study of Fixed Dose Combination of DWJ1386 Compared With Co-administration of DWC20155 and DWC20156 in Healthy Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

March 31, 2017

Conditions
Healthy
Interventions
DRUG

Co-administration of DWC20155 and DWC20156

DRUG

DWJ1386 Tab.

Trial Locations (1)

614-735

RECRUITING

Busan Paik Hospital, Busan

Sponsors
All Listed Sponsors
lead

Daewoong Pharmaceutical Co. LTD.

INDUSTRY